| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients
|
Nachit, Maxime
|
|
|
3 |
4 |
p.
|
article
|
| 2 |
A new high-content screening assay of the entire hepatitis B virus life cycle identifies novel antivirals
|
Yang, Jaewon
|
|
|
3 |
4 |
p.
|
article
|
| 3 |
A novel therapeutic HBV vaccine candidate induces strong polyfunctional cytotoxic T cell responses in mice
|
Boudewijns, Robbert
|
|
|
3 |
4 |
p.
|
article
|
| 4 |
A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation
|
Nevens, Frederik
|
|
|
3 |
4 |
p.
|
article
|
| 5 |
Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis
|
Kurosaki, Shigeyuki
|
|
|
3 |
4 |
p.
|
article
|
| 6 |
Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?
|
Izzy, Manhal
|
|
|
3 |
4 |
p.
|
article
|
| 7 |
Contents
|
|
|
|
3 |
4 |
p.
|
article
|
| 8 |
Copyright and information
|
|
|
|
3 |
4 |
p.
|
article
|
| 9 |
Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis
|
Erhardtsen, Elisabeth
|
|
|
3 |
4 |
p.
|
article
|
| 10 |
Editorial Board page
|
|
|
|
3 |
4 |
p.
|
article
|
| 11 |
Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis
|
Kaur, Savneet
|
|
|
3 |
4 |
p.
|
article
|
| 12 |
Embedding assessment of liver fibrosis into routine diabetic review in primary care
|
Mansour, Dina
|
|
|
3 |
4 |
p.
|
article
|
| 13 |
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
|
Younossi, Zobair M.
|
|
|
3 |
4 |
p.
|
article
|
| 14 |
Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
|
Meijnikman, Abraham Stijn
|
|
|
3 |
4 |
p.
|
article
|
| 15 |
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
|
Poynard, Thierry
|
|
|
3 |
4 |
p.
|
article
|
| 16 |
HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?
|
Costentin, Charlotte E.
|
|
|
3 |
4 |
p.
|
article
|
| 17 |
Hepatic microbiome in healthy lean and obese humans
|
Suppli, Malte Palm
|
|
|
3 |
4 |
p.
|
article
|
| 18 |
Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency
|
Karatas, Esra
|
|
|
3 |
4 |
p.
|
article
|
| 19 |
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
|
Laschtowitz, Alena
|
|
|
3 |
4 |
p.
|
article
|
| 20 |
Human hepatitis D virus-specific T cell epitopes
|
Kohsar, Matin
|
|
|
3 |
4 |
p.
|
article
|
| 21 |
Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions
|
Healy, Katie
|
|
|
3 |
4 |
p.
|
article
|
| 22 |
Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas
|
Chopinet, Sophie
|
|
|
3 |
4 |
p.
|
article
|
| 23 |
Novel vectors and approaches for gene therapy in liver diseases
|
Maestro, Sheila
|
|
|
3 |
4 |
p.
|
article
|
| 24 |
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
|
Iwakiri, Yasuko
|
|
|
3 |
4 |
p.
|
article
|
| 25 |
Reply to: “Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?”
|
Allaire, Manon
|
|
|
3 |
4 |
p.
|
article
|
| 26 |
Using cell-free DNA for HCC surveillance and prognosis
|
Tran, Nguyen H.
|
|
|
3 |
4 |
p.
|
article
|
Journal description